Incannex Healthcare Limited – NASDAQ:IXHL
Incannex Healthcare Limited stock price today
Incannex Healthcare Limited stock price monthly change
Incannex Healthcare Limited stock price quarterly change
Incannex Healthcare Limited stock price yearly change
Incannex Healthcare Limited key metrics
Market Cap | 30.16M |
Enterprise value | 67.44M |
P/E | -0.11 |
EV/Sales | N/A |
EV/EBITDA | -4.52 |
Price/Sales | N/A |
Price/Book | 1.52 |
PEG ratio | N/A |
EPS | -1.69 |
Revenue | N/A |
EBITDA | -25.93M |
Income | -24.27M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIncannex Healthcare Limited stock price history
Incannex Healthcare Limited stock forecast
Incannex Healthcare Limited financial statements
| Jun 2022 | 782.38K | -6.94M | -887.35% |
|---|---|---|---|
| Mar 2023 | 0 | -3.57M | |
| Jun 2023 | 1.01M | -7.73M | -762.96% |
| Mar 2024 | 0 | -6.03M |
| Sep 2022 | 9469902 | 502.63K | 5.31% |
|---|---|---|---|
| Dec 2022 | 64778280 | 885.13K | 1.37% |
| Jun 2023 | 58640988 | 2.95M | 5.04% |
| Mar 2024 | 17250000 | 3.11M | 18.04% |
| Jun 2022 | -6.90M | 29.27K | 25.08M |
|---|---|---|---|
| Mar 2023 | 0 | 0 | 538.78K |
| Jun 2023 | -3.59K | -315.65K | 8.11M |
| Mar 2024 | -4.35M | 6K | 0 |
Incannex Healthcare Limited alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Incannex Healthcare Limited other data
-
What's the price of Incannex Healthcare Limited stock today?
One share of Incannex Healthcare Limited stock can currently be purchased for approximately $0.39.
-
When is Incannex Healthcare Limited's next earnings date?
Unfortunately, Incannex Healthcare Limited's (IXHL) next earnings date is currently unknown.
-
Does Incannex Healthcare Limited pay dividends?
No, Incannex Healthcare Limited does not pay dividends.
-
How much money does Incannex Healthcare Limited make?
Incannex Healthcare Limited has a market capitalization of 30.16M.
-
What is Incannex Healthcare Limited's stock symbol?
Incannex Healthcare Limited is traded on the NASDAQ under the ticker symbol "IXHL".
-
What is Incannex Healthcare Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Incannex Healthcare Limited?
Shares of Incannex Healthcare Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Incannex Healthcare Limited have?
As Jul 2024, Incannex Healthcare Limited employs 3 workers.
-
When Incannex Healthcare Limited went public?
Incannex Healthcare Limited is publicly traded company for more then 3 years since IPO on 2 Mar 2022.
-
What is Incannex Healthcare Limited's official website?
The official website for Incannex Healthcare Limited is incannex.com.au.
-
Where are Incannex Healthcare Limited's headquarters?
Incannex Healthcare Limited is headquartered at 207/11 Solent Circuit, Sydney, NSW.
-
How can i contact Incannex Healthcare Limited?
Incannex Healthcare Limited's mailing address is 207/11 Solent Circuit, Sydney, NSW and company can be reached via phone at +61 425 703 805.
Incannex Healthcare Limited company profile:
Incannex Healthcare Limited
incannex.com.auNASDAQ
9
Drug Manufacturers - Specialty & Generic
Healthcare
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.
Sydney, NSW 2153
CIK: 0001873875
ISIN: US45333F1093
CUSIP: 45333L106
